Unintended consequences: avoiding restenosis and stent thrombosis.
作者信息
Wilson James M
出版信息
Tex Heart Inst J. 2010;37(3):341-2.
Abstract
摘要
相似文献
1
Unintended consequences: avoiding restenosis and stent thrombosis.意外后果：避免再狭窄和支架血栓形成。
Tex Heart Inst J. 2010;37(3):341-2.
2
The excel stent: a good DES, but can we really stop clopidogrel after 6 months?爱克塞尔支架：一种不错的药物洗脱支架，但6个月后我们真的可以停用氯吡格雷吗？
JACC Cardiovasc Interv. 2009 Apr;2(4):310-1. doi: 10.1016/j.jcin.2009.01.005.
3
Drug-eluting stents: safe but not sufficient.药物洗脱支架：安全但并不足够。
JACC Cardiovasc Interv. 2009 Jun;2(6):513-4. doi: 10.1016/j.jcin.2009.04.002.
4
Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.可生物降解聚合物涂层西罗莫司洗脱支架在“真实世界”实践中的安全性和有效性：18个月临床及9个月血管造影结果
JACC Cardiovasc Interv. 2009 Apr;2(4):303-9. doi: 10.1016/j.jcin.2008.12.013.
5
Drug-eluting stent thrombosis.药物洗脱支架血栓形成
Ther Adv Cardiovasc Dis. 2009 Feb;3(1):45-52. doi: 10.1177/1753944708096280. Epub 2008 Sep 18.
6
Optimizing the impact of primary percutaneous coronary intervention in acute myocardial infarction.
Catheter Cardiovasc Interv. 2011 Feb 1;77(2):201. doi: 10.1002/ccd.22952.
7
Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study.新发冠状动脉病变高危再狭窄患者中内皮祖细胞捕获支架与 Taxus Liberté 支架的两年随访：一项随机、单中心、先导研究。
Catheter Cardiovasc Interv. 2011 Aug 1;78(2):189-95. doi: 10.1002/ccd.23143. Epub 2011 Jul 15.
8
Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.药物洗脱支架置入1659天后发生支架内血栓形成：病例报告及文献综述
Tex Heart Inst J. 2010;37(3):343-6.
9
3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.西罗莫司洗脱支架与血管内近距离放射治疗治疗支架内再狭窄（SISR）试验的3年随访
JACC Cardiovasc Interv. 2008 Aug;1(4):439-48. doi: 10.1016/j.jcin.2008.05.010.
10
Gone but not forgotten: the case for drug-eluting stents in percutaneous revascularization of the chronic coronary total occlusion.虽已不再使用但仍未被遗忘：药物洗脱支架在慢性冠状动脉完全闭塞经皮血管重建中的应用情况
JACC Cardiovasc Interv. 2009 Dec;2(12):1266-8. doi: 10.1016/j.jcin.2009.10.007.
本文引用的文献
1
Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.药物洗脱支架置入1659天后发生支架内血栓形成：病例报告及文献综述
Tex Heart Inst J. 2010;37(3):343-6.
2
Five-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) Registry.应用西罗莫司洗脱支架治疗慢性完全闭塞病变的 5 年临床结果：鹿特丹心脏病学医院-（研究）注册研究中雷帕霉素洗脱支架的评估结果
Catheter Cardiovasc Interv. 2009 Dec 1;74(7):979-86. doi: 10.1002/ccd.22230.
Zotero 插件